nlmixr2 is Becoming an R Consortium Working Group

The vision of nlmixr2 is to develop a R-based open-source nonlinear mixed-effects modeling software package that can compete with commercial pharmacometric tools and is suitable for regulatory submissions.
pharma
submissions
clinical research
announcements
Author

R Consortium

Published

November 26, 2025

Original post on the nlmixr2 project blog is here.

From the nlmixr2 project blog:

We are very excited to announce we are joining the R consortium as a Working Group (WG). Our vision will remain the same:

“The vision of nlmixr2 is to develop a R-based open-source nonlinear mixed-effects modeling software package that can compete with commercial pharmacometric tools and is suitable for regulatory submissions.”

Read the full post here.

Get involved in the nlmixr2 working group

The nlmixr2 working group is open to anyone interested in contributing to the project. You can get involved by:

Main repo: https://github.com/nlmixr2/nlmixr2
Issues: https://github.com/nlmixr2/nlmixr2/issues
Discussions: https://github.com/nlmixr2/nlmixr2/discussions